SCHEMBL18089943

SCHEMBL18089943

c1ccc([Si](c2ccccc2)(c2nccc3c2oc2ccc(-c4ccc5oc6ccccc6c5c4)cc23)c2nccc3c2oc2ccc(-c4ccc5oc6ccccc6c5c4)cc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
NPC1 O15118 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 2/20 0.38
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
ALOX5 P09917 1/20 0.36
LMNA P02545 5/20 0.36
PLA2G10 O15496 1/20 0.35
AHR P35869 1/20 0.35
USP2 O75604 1/20 0.34
HTT P42858 1/20 0.34
LIMK1 P53667 1/20 0.34
CASP3 P42574 2/20 0.33
SENP7 Q9BQF6 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18089942 0.91 MAPT (0.38) MAPTNPC1SMN1; SMN2RAB9AALDH1A1
SCHEMBL18089917 0.90 ALOX5 (0.50) MAPTNPC1SMN1; SMN2RAB9AALDH1A1
SCHEMBL18090098 0.90 NPC1 (0.39) MAPTNPC1SMN1; SMN2RAB9AALDH1A1
SCHEMBL18089946 0.90 NPC1 (0.38) MAPTNPC1SMN1; SMN2RAB9AALDH1A1
SCHEMBL18090046 0.86 NPC1 (0.35) MAPTNPC1LIMK1
SCHEMBL18089941 0.83 KDM4E (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL18090133 0.83 NPC1 (0.34) MAPTNPC1ALOX5
SCHEMBL18089998 0.81 LIMK1 (0.35) MAPTNPC1ALOX5LIMK1
SCHEMBL18090003 0.81 LIMK1 (0.31) MAPTNPC1LIMK1
SCHEMBL18090106 0.81 NPC1 (0.33) MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780316-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-10-03 US disclosed
US-9780316-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-10-03 US disclosed
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-09-22 US disclosed
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES RB1, LEF1, BRD1 MAPT 3821/4885NPC1 4402/4885SMN1; SMN2 2065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.